gefitinib has been researched along with abt-199 in 1 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (abt-199) | Trials (abt-199) | Recent Studies (post-2010) (abt-199) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 1,483 | 150 | 1,469 |
| Protein | Taxonomy | gefitinib (IC50) | abt-199 (IC50) |
|---|---|---|---|
| Apoptosis regulator Bcl-2 | Homo sapiens (human) | 0.0392 | |
| Bcl-2-like protein 1 | Homo sapiens (human) | 0.0667 | |
| Induced myeloid leukemia cell differentiation protein Mcl-1 | Homo sapiens (human) | 0.0044 | |
| Aspartyl/asparaginyl beta-hydroxylase | Homo sapiens (human) | 1.445 | |
| Bcl-2-related protein A1 | Homo sapiens (human) | 0.0044 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arsiwala, TA; Blethen, KE; Fladeland, R; Gao, W; Liu, Z; Lockman, PR; Marshall, KL; Mohammad, A; Saralkar, P; Shah, N; Sprowls, SA | 1 |
1 other study(ies) available for gefitinib and abt-199
| Article | Year |
|---|---|
Overcoming the acquired resistance to gefitinib in lung cancer brain metastasis in vitro and in vivo.
Topics: Acrylamides; Aniline Compounds; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Gefitinib; Lung Neoplasms; Mice; Mice, Nude; Proto-Oncogene Proteins c-bcl-2; Sulfonamides | 2021 |